Ionis Pharmaceuticals Inc (IONS)
34.34
-2.89
(-7.76%)
USD |
NASDAQ |
Nov 15, 16:00
34.34
0.00 (0.00%)
Pre-Market: 08:32
Ionis Pharmaceuticals Price: 34.34 for Nov. 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 37.25 | 37.29 | 34.24 | 34.34 | 1.787M |
| Nov 14, 2024 | 37.50 | 37.78 | 36.78 | 37.23 | 1.921M |
| Nov 13, 2024 | 37.82 | 38.42 | 37.51 | 37.78 | 914175.0 |
| Nov 12, 2024 | 38.50 | 38.77 | 37.60 | 37.77 | 937006.0 |
| Nov 11, 2024 | 39.44 | 40.06 | 38.81 | 38.88 | 825818.0 |
| Nov 08, 2024 | 38.56 | 39.58 | 38.50 | 39.19 | 1.019M |
| Nov 07, 2024 | 39.50 | 39.80 | 38.16 | 38.46 | 986009.0 |
| Nov 06, 2024 | 39.95 | 39.96 | 37.18 | 39.04 | 1.729M |
| Nov 05, 2024 | 38.01 | 39.20 | 37.53 | 38.80 | 1.274M |
| Nov 04, 2024 | 38.64 | 38.89 | 38.25 | 38.44 | 1.190M |
| Nov 01, 2024 | 38.60 | 39.02 | 38.19 | 38.76 | 739908.0 |
| Oct 31, 2024 | 39.13 | 39.13 | 38.26 | 38.39 | 910036.0 |
| Oct 30, 2024 | 39.37 | 40.12 | 38.95 | 39.26 | 748661.0 |
| Oct 29, 2024 | 40.31 | 40.58 | 39.34 | 39.71 | 1.183M |
| Oct 28, 2024 | 39.31 | 40.41 | 39.21 | 40.36 | 1.000M |
| Oct 25, 2024 | 38.99 | 39.72 | 38.87 | 39.19 | 1.036M |
| Oct 24, 2024 | 38.50 | 38.95 | 38.40 | 38.77 | 859788.0 |
| Oct 23, 2024 | 38.83 | 38.90 | 38.32 | 38.42 | 1.054M |
| Oct 22, 2024 | 38.90 | 39.08 | 38.53 | 38.68 | 881357.0 |
| Oct 21, 2024 | 39.41 | 39.55 | 38.36 | 39.00 | 1.643M |
| Oct 18, 2024 | 38.56 | 39.72 | 38.56 | 39.68 | 1.343M |
| Oct 17, 2024 | 39.07 | 39.29 | 38.47 | 38.49 | 1.891M |
| Oct 16, 2024 | 37.83 | 39.35 | 37.65 | 39.16 | 2.115M |
| Oct 15, 2024 | 38.69 | 38.96 | 37.83 | 37.84 | 1.060M |
| Oct 14, 2024 | 38.37 | 38.74 | 38.28 | 38.63 | 949495.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.61
Minimum
Dec 01 2021
65.27
Maximum
Dec 16 2019
44.27
Average
42.49
Median
Price Benchmarks
| Biogen Inc | 159.99 |
| Alnylam Pharmaceuticals Inc | 235.56 |
| Biomarin Pharmaceutical Inc | 63.42 |
| Amicus Therapeutics Inc | 9.68 |
| Arbutus Biopharma Corp | 3.64 |
Price Related Metrics
| PS Ratio | 6.240 |
| Price to Book Value | 8.185 |
| Earnings Yield | -7.11% |
| Market Cap | 5.422B |